KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diebold Nixdorf (DBD) Research & Development (2016 - 2025)

Diebold Nixdorf's Research & Development history spans 17 years, with the latest figure at $21.4 million for Q4 2025.

  • For Q4 2025, Research & Development fell 10.46% year-over-year to $21.4 million; the TTM value through Dec 2025 reached $86.8 million, down 7.26%, while the annual FY2025 figure was $86.7 million, 7.37% down from the prior year.
  • Research & Development reached $21.4 million in Q4 2025 per DBD's latest filing, up from $20.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $35.6 million in Q2 2021 to a low of $12.0 million in Q3 2023.
  • Average Research & Development over 5 years is $25.9 million, with a median of $25.4 million recorded in 2023.
  • Peak YoY movement for Research & Development: plummeted 55.06% in 2023, then surged 95.0% in 2024.
  • A 5-year view of Research & Development shows it stood at $31.0 million in 2021, then fell by 7.74% to $28.6 million in 2022, then plummeted by 58.04% to $12.0 million in 2023, then skyrocketed by 99.17% to $23.9 million in 2024, then dropped by 10.46% to $21.4 million in 2025.
  • Per Business Quant, the three most recent readings for DBD's Research & Development are $21.4 million (Q4 2025), $20.3 million (Q3 2025), and $22.4 million (Q2 2025).